Psoriasis: Interplay between dysbiosis and host immune system.
- Publisher:
- Elsevier
- Publication Type:
- Journal Article
- Citation:
- Autoimmun Rev, 2022, 21, (11), pp. 103169
- Issue Date:
- 2022-11
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
1-s2.0-S1568997222001392-main.pdf | Published version | 1.16 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Kapoor, B | |
dc.contributor.author | Gulati, M | |
dc.contributor.author | Rani, P | |
dc.contributor.author | Gupta, R | |
dc.date.accessioned | 2023-07-08T00:48:47Z | |
dc.date.available | 2022-08-07 | |
dc.date.available | 2023-07-08T00:48:47Z | |
dc.date.issued | 2022-11 | |
dc.identifier.citation | Autoimmun Rev, 2022, 21, (11), pp. 103169 | |
dc.identifier.issn | 1568-9972 | |
dc.identifier.issn | 1873-0183 | |
dc.identifier.uri | http://hdl.handle.net/10453/171323 | |
dc.description.abstract | With advancement in human microbiome research, an increasing number of scientific evidences have endorsed the key role of both gut and skin microbiota in the pathogenesis of psoriasis. Microbiome dysbiosis, characterized by altered diversity and composition, as well as rise of pathobionts, have been identified as possible triggers for recurrent episodes of psoriasis. Mechanistically, gut dysbiosis leads to "leaky gut syndrome" via disruption of epithelial bilayer, thereby, resulting in translocation of bacteria and other endotoxins to systemic circulation, which in turn, results in inflammatory response. Similarly, skin dysbiosis disrupts the cutaneous homeostasis, leading to invasion of bacteria and other pathogens to deeper layers of skin or even systemic circulation further enhanced by injury caused by pruritus-induced scratching, and elicit innate and adaptive inflammation. The present review explores the correlation of both skin and gut microbiota dysbiosis with psoriasis. Also, the studies highlighting the potential of bacteriotherapeutic approaches including probiotics, prebiotics, metabiotics, and fecal microbiota transplantation for the management of psoriasis have been discussed. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | Elsevier | |
dc.relation.ispartof | Autoimmun Rev | |
dc.relation.isbasedon | 10.1016/j.autrev.2022.103169 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 1107 Immunology | |
dc.subject.classification | Immunology | |
dc.subject.classification | 3202 Clinical sciences | |
dc.subject.classification | 3204 Immunology | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Dysbiosis | |
dc.subject.mesh | Fecal Microbiota Transplantation | |
dc.subject.mesh | Gastrointestinal Microbiome | |
dc.subject.mesh | Prebiotics | |
dc.subject.mesh | Probiotics | |
dc.subject.mesh | Psoriasis | |
dc.subject.mesh | Immune System | |
dc.subject.mesh | Bacteria | |
dc.subject.mesh | Immune System | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Bacteria | |
dc.subject.mesh | Psoriasis | |
dc.subject.mesh | Probiotics | |
dc.subject.mesh | Prebiotics | |
dc.subject.mesh | Dysbiosis | |
dc.subject.mesh | Gastrointestinal Microbiome | |
dc.subject.mesh | Fecal Microbiota Transplantation | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Dysbiosis | |
dc.subject.mesh | Fecal Microbiota Transplantation | |
dc.subject.mesh | Gastrointestinal Microbiome | |
dc.subject.mesh | Prebiotics | |
dc.subject.mesh | Probiotics | |
dc.subject.mesh | Psoriasis | |
dc.subject.mesh | Immune System | |
dc.subject.mesh | Bacteria | |
dc.title | Psoriasis: Interplay between dysbiosis and host immune system. | |
dc.type | Journal Article | |
utslib.citation.volume | 21 | |
utslib.location.activity | Netherlands | |
utslib.for | 1107 Immunology | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health/Public Health | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2023-07-08T00:48:46Z | |
pubs.issue | 11 | |
pubs.publication-status | Published | |
pubs.volume | 21 | |
utslib.citation.issue | 11 |
Abstract:
With advancement in human microbiome research, an increasing number of scientific evidences have endorsed the key role of both gut and skin microbiota in the pathogenesis of psoriasis. Microbiome dysbiosis, characterized by altered diversity and composition, as well as rise of pathobionts, have been identified as possible triggers for recurrent episodes of psoriasis. Mechanistically, gut dysbiosis leads to "leaky gut syndrome" via disruption of epithelial bilayer, thereby, resulting in translocation of bacteria and other endotoxins to systemic circulation, which in turn, results in inflammatory response. Similarly, skin dysbiosis disrupts the cutaneous homeostasis, leading to invasion of bacteria and other pathogens to deeper layers of skin or even systemic circulation further enhanced by injury caused by pruritus-induced scratching, and elicit innate and adaptive inflammation. The present review explores the correlation of both skin and gut microbiota dysbiosis with psoriasis. Also, the studies highlighting the potential of bacteriotherapeutic approaches including probiotics, prebiotics, metabiotics, and fecal microbiota transplantation for the management of psoriasis have been discussed.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph